Mesenchymal Stem Cell Implantation in Knee Osteoarthritis: An Assessment of the Factors Influencing Clinical Outcomes

American Journal of Sports Medicine

Volumn 43, Issue 9, 2015, Pages 2293-2301

  Kim, Yong Sang ^a   Choi, Yun Jin ^a   Koh, Yong Gon ^a  

^a Yonsei Sarang Hospital   (South Korea)

Author keywords

implantation; knee; mesenchymal stem cell; osteoarthritis; prognostic factors

Indexed keywords

FIBRIN GLUE;

AGE DISTRIBUTION; AGED; ARTICULAR CARTILAGE; CARTILAGE DISEASES; FEMALE; HUMAN; KNEE; LYSHOLM SCORE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PHYSIOLOGY; PROCEDURES; REGENERATION; RETROSPECTIVE STUDY; SEX RATIO; TISSUE SCAFFOLD; VERY ELDERLY; YOUNG ADULT;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; FEMALE; FIBRIN TISSUE ADHESIVE; HUMANS; KNEE JOINT; LYSHOLM KNEE SCORE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATIENT SATISFACTION; REGENERATION; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; TISSUE SCAFFOLDS; YOUNG ADULT;

EID: 84940779907     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546515588317     Document Type: Article

References (44)

1. Ahmed TA, Giulivi A, Griffith M, Hincke M,. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Eng Part A. 2011; 17: 323-335.
2. Badri A, Burkhardt J,. Arthroscopic debridement of unicompartmental arthritis: fact or fiction? Clin Sports Med. 2014; 33: 23-41.
3. Bae DK, Yoon KH, Song SJ,. Cartilage healing after microfracture in osteoarthritic knees. Arthroscopy. 2006; 22: 367-374.
4. Barry F, Murphy M,. Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol. 2013; 9: 584-594.
5. Basad E, Ishaque B, Bachmann G, Sturz H, Steinmeyer J,. Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study. Knee Surg Sports Traumatol Arthrosc. 2010; 18: 519-527.
6. Bodle JC, Teeter SD, Hluck BH, Hardin JW, Bernacki SH, Loboa EG,. Age-related effects on the potency of human adipose-derived stem cells: creation and evaluation of superlots and implications for musculoskeletal tissue engineering applications. Tissue Eng Part C Methods. 2014; 20: 972-983.
7. Caldwell KL, Wang J,. Cell-based articular cartilage repair: the link between development and regeneration. Osteoarthritis Cartilage. 2015; 23: 351-362.
8. Caplan AI, Dennis JE,. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98: 1076-1084.
9. Chang HX, Yang L, Li Z, Chen G, Dai G,. Age-related biological characterization of mesenchymal progenitor cells in human articular cartilage. Orthopedics. 2011; 34: e382-e388.
10. Chang J, Rasamny JJ, Park SS,. Injectable tissue-engineered cartilage using a fibrin sealant. Arch Facial Plast Surg. 2007; 9: 161-166.
11. Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT,. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J Transl Med. 2014; 12: 8.
12. Cucchiarini M, Madry H,. Use of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches. Curr Rheumatol Rep. 2014; 16: 449.
13. Dare EV, Griffith M, Poitras P,. Fibrin sealants from fresh or fresh/frozen plasma as scaffolds for in vitro articular cartilage regeneration. Tissue Eng Part A. 2009; 15: 2285-2297.
14. Diekman BO, Guilak F,. Stem cell-based therapies for osteoarthritis: challenges and opportunities. Curr Opin Rheumatol. 2013; 25: 119-126.
15. Dos-Anjos Vilaboa S, Navarro-Palou M, Llull R,. Age influence on stromal vascular fraction cell yield obtained from human lipoaspirates. Cytotherapy. 2014; 16: 1092-1097.
16. Ebert JR, Smith A, Edwards PK, Hambly K, Wood DJ, Ackland TR,. Factors predictive of outcome 5 years after matrix-induced autologous chondrocyte implantation in the tibiofemoral joint. Am J Sports Med. 2013; 41: 1245-1254.
17. Goldring MB,. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis. 2012; 4: 269-285.
18. Harris JD, Siston RA, Pan X, Flanigan DC,. Autologous chondrocyte implantation: a systematic review. J Bone Joint Surg Am. 2010; 92: 2220-2233.
19. Ho W, Tawil B, Dunn JC, Wu BM,. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng. 2006; 12: 1587-1595.
20. Irrgang JJ, Anderson AF, Boland AL,. Development and validation of the International Knee Documentation Committee subjective knee form. Am J Sports Med. 2001; 29: 600-613.
21. Jo CH, Lee YG, Shin WH,. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014; 32: 1254-1266.
22. Jung SN, Rhie JW, Kwon H,. In vivo cartilage formation using chondrogenic-differentiated human adipose-derived mesenchymal stem cells mixed with fibrin glue. J Craniofac Surg. 2010; 21: 468-472.
23. Kaul G, Cucchiarini M, Remberger K, Kohn D, Madry H,. Failed cartilage repair for early osteoarthritis defects: a biochemical, histological and immunohistochemical analysis of the repair tissue after treatment with marrow-stimulation techniques. Knee Surg Sports Traumatol Arthrosc. 2012; 20: 2315-2324.
24. Kellgren JH, Lawrence JS,. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16: 494-502.
25. Kim I, Lee SK, Yoon JI, Kim da E, Kim M, Ha H,. Fibrin glue improves the therapeutic effect of MSCs by sustaining survival and paracrine function. Tissue Eng Part A. 2013; 19: 2373-2381.
26. Kim YS, Choi YJ, Suh DS,. Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold? Am J Sports Med. 2015; 42 (1): 176-185.
27. Knutsen G, Engebretsen L, Ludvigsen TC,. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am. 2004; 86: 455-464.
28. Koh YG, Choi YJ, Kwon OR, Kim YS,. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am J Sports Med. 2014; 42: 1628-1637.
29. Koh YG, Choi YJ, Kwon SK, Kim YS, Yeo JE,. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015; 23 (5): 1308-1316.
30. Koh YG, Jo SB, Kwon OR,. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy. 2013; 29: 748-755.
31. Kurtz S, Ong K, Lau E, Mowat F, Halpern M,. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007; 89: 780-785.
32. Lee GW, Son JH, Kim JD, Jung GH,. Is platelet-rich plasma able to enhance the results of arthroscopic microfracture in early osteoarthritis and cartilage lesion over 40 years of age? Eur J Orthop Surg Traumatol. 2013; 23: 581-587.
33. Loeser RF, Goldring SR, Scanzello CR, Goldring MB,. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012; 64: 1697-1707.
34. Luyten FP, Denti M, Filardo G, Kon E, Engebretsen L,. Definition and classification of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2012; 20: 401-406.
35. Niemeyer P, Pestka JM, Salzmann GM, Sudkamp NP, Schmal H,. Influence of cell quality on clinical outcome after autologous chondrocyte implantation. Am J Sports Med. 2012; 40: 556-561.
36. Noth U, Steinert AF, Tuan RS,. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol. 2008; 4: 371-380.
37. Oreffo RO, Cooper C, Mason C, Clements M,. Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 2005; 1: 169-178.
38. Orozco L, Munar A, Soler R,. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation. 2014; 97: e66-e68.
39. Peterson L, Vasiliadis HS, Brittberg M, Lindahl A,. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med. 2010; 38: 1117-1124.
40. Roldan M, Macias-Gonzalez M, Garcia R, Tinahones FJ, Martin M,. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J. 2011; 25: 4111-4126.
41. Sakata K, Furumatsu T, Abe N, Miyazawa S, Sakoma Y, Ozaki T,. Histological analysis of failed cartilage repair after marrow stimulation for the treatment of large cartilage defect in medial compartmental osteoarthritis of the knee. Acta Med Okayama. 2013; 67: 65-74.
42. Salzmann GM, Niemeyer P, Steinwachs M, Kreuz PC, Sudkamp NP, Mayr HO,. Cartilage repair approach and treatment characteristics across the knee joint: a European survey. Arch Orthop Trauma Surg. 2011; 131: 283-291.
43. Tegner Y, Lysholm J,. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res. 1985; 198: 43-49.
44. Wu LW, Wang YL, Christensen JM,. Donor age negatively affects the immunoregulatory properties of both adipose and bone marrow derived mesenchymal stem cells. Transpl Immunol. 2014; 30: 122-127.